KLTO
Klotho Neurosciences
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
News
- Klotho Neurosciences begins development of the “Klotho Clock,” a biological aging diagnostic tool powered by epigenetics and AIFeb 24, 2026
- Klotho Neurosciences initiates manufacturing of KLTO-202 product candidate using AAVnerGene's platform technologyAug 13, 2025
- Klotho Neurosciences, Inc. to expand development programs beyond neurologyJul 25, 2025
- Klotho Neurosciences granted FDA orphan drug designation for KLTO-202 to treat amyotrophic lateral sclerosis (ALS)Jul 10, 2025
- Klotho Neurosciences and Okinawa Research Center announce study to assess Klotho gene and protein levels in the world's longest-lived populationJun 24, 2025